Snippet OPEN LABEL PROTOCOL OR OPEN PROTOCOL IND
Post# of 148165
OPEN LABEL PROTOCOL OR OPEN PROTOCOL IND
These are usually uncontrolled studies, carried out to obtain additional safety data (Phase 3 studies). They are typically used when the controlled trial has ended and treatment is continued so that the subjects and the controls may continue to receive the benefits of the investigational drug until marketing approval is obtained. These studies require prospective Institutional Review Board (IRB) review and informed consent.